Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Michael Shan"'
Autor:
Kyle S. Bilodeau, Frank F. Yang, Michael Shang, Audrey Mossman, David C. Mauchley, Scott DeRoo, Christopher R. Burke
Publikováno v:
The Cardiothoracic Surgeon, Vol 32, Iss 1, Pp 1-10 (2024)
Abstract Background The Ross procedure is a technically complex operation to address the pathology of the aortic valve. Prior attempts at widespread implementation have been plagued with variations in effectiveness. We report our initial programmatic
Externí odkaz:
https://doaj.org/article/03873ac08875476a8d99574607488f21
Autor:
Gabrielle Gilmer, BChE, Albert Lin, MD, Michael Shannon, BS, Asher Mirvish, BA, Nicholas Aloi, BS, Forrest Shooster, BS, Justin J. Greiner, MD
Publikováno v:
JSES Reviews, Reports, and Techniques, Vol 3, Iss 4, Pp 499-505 (2023)
Background: Baseball and softball are popular sports with similar rates of injury, especially among pitchers. However, parity between the two sports is lacking, as baseball receives greater research attention than softball. The purpose of this study
Externí odkaz:
https://doaj.org/article/f32eae6a7dcd40b59618145084b7288b
Autor:
Ho, Michael (Shan-Hui) *
Publikováno v:
In BioSystems 2005 80(3):233-250
Publikováno v:
In BioSystems 2004 73(2):117-130
Publikováno v:
In Parallel Computing 2004 30(9):1109-1125
Autor:
Michael Shan, Kun Chen
Publikováno v:
Contemporary Clinical Trials. 29:32-41
The common objective of oncology phase II trials is to evaluate the anti-tumor activity of a new agent and to determine whether the new drug warrants further investigation. For cancer drugs that significantly shrink tumors, response (CR and PR) rate
Autor:
Carlos A. Dujovne, Peter O. Kwiterovich, Jonathan L. Isaacsohn, Ronald Brazg, William Insull, Michael Shan, Ma Patrick, Elizabeth Shugrue‐Crowley, Steven Ripa, Robert Tota, Evan A. Stein
Publikováno v:
Clinical Cardiology. 24:1-9
Background: Statins are the agents of choice in reducing elevated plasma low‐density lipoprotein cholesterol (LDL‐C). Hypothesis: Cerivastatin 0.8 mg has greater long‐term efficacy in reducing LDL‐C than pravastatin 40 mg in primary hyperchol
Autor:
Renee Perroncel, Michael Shan, Karen Westberry, Thomas Bock, Margaret Drehobl, David Williams, Allen Heyd, Frank E. Lucente, Bruce Pistorius
Publikováno v:
Infectious Diseases in Clinical Practice. 8:387-395
Publikováno v:
Annals of Otology, Rhinology & Laryngology. 108:360-367
This multicenter, randomized, double-blind trial compared the efficacy and safety of ciprofloxacin (CIP; 500 mg twice daily for 10 days, placebo for 4 days) to those of clarithromycin (CLARI; 500 mg twice daily for 14 days) in 560 adults with clinica
Autor:
James M. McCarty, Robert Tosiello, Michael Shan, Richard M. Tucker, Werner Huck, Roger Echols, Allen Heyd, George A. Richard
Publikováno v:
The American Journal of Medicine. 106:292-299
PURPOSE: Bladder infections are very common in otherwise healthy women, and short-course antimicrobial treatment appears effective for many episodes of cystitis. This study reports the results of short-course ciprofloxacin, ofloxacin, and trimethopri